Pro/Con: Insurance coverage the next logical step for medical cannabis

Key Takeaways:

• Medical cannabis is already in use by many patients, who report significant benefits.
• A physician advocates expanding insurance policies to encompass this emerging therapy.
• Published on November 16, 2025, in Duluth News Tribune, the column highlights practical and political considerations.
• The author specifically calls on insurers to acknowledge and reimburse the cost of medical cannabis.
• The piece underscores the need for broader acceptance and policy reforms.

The Growing Role of Medical Cannabis

Medical cannabis has become a talking point in the healthcare community, with many patients reporting relief from chronic conditions. While its use remains a topic of debate, evidence of its therapeutic benefits continues to gain recognition.

Why Insurance Coverage Matters

“I cannot ignore treatments my patients are already using and benefiting from. Insurance companies should not ignore them either.” This statement underscores the key question at hand: if patients find effective relief, why shouldn’t these treatments be covered by insurance like other prescribed therapies? According to this view, expanding insurance coverage could alleviate financial burdens on those who rely on medical cannabis for relief.

A Physician’s Perspective

Mikhail Kogan, the physician behind this opinion piece, stresses that the positive experiences of his patients merit broader consideration. He sees insurance coverage as the next logical step, aligning with how other emerging treatments have transitioned from niche options to standard, insured care. His goal is to bring these conversations into the mainstream medical community and underscore the pragmatic need for policy updates.

Considering the Policy Implications

The push for insurance coverage raises both practical and political questions. On the policy front, including medical cannabis in standard insurance benefits could signal a significant shift in public acceptance. Critics may argue that more research is needed to justify coverage, but proponents counter that real-life patient outcomes already show compelling results.

The Path Forward

Ultimately, the columnist highlights a pressing need for insurers, policymakers, and medical professionals to align better with evolving patient needs. The piece, published on November 16, 2025, in the Duluth News Tribune, ends with a clarion call: that insurance providers should review their policies in light of growing patient demand and positive clinical experiences. Only then, the author suggests, can the healthcare system truly serve its diverse patient population.